Piramal Pharma Sees Significant Surge in Open Interest Amid Active Derivatives Trading

Piramal Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable increase in open interest today. The latest open interest stands at 12,905 contracts, reflecting a rise of 1,389 contracts or 12.06% from the previous open interest of 11,516. This surge in open interest coincides with a trading volume of 12,738 contracts, indicating active participation in the derivatives market.
In terms of price performance, Piramal Pharma has outperformed its sector by 1.04%, with the stock gaining 1.54% over the last two days. Today, it reached an intraday high of Rs 208.64, marking a 2.61% increase. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.

Despite the positive price movement, there has been a decline in investor participation, with delivery volume dropping by 46.95% compared to the 5-day average. The stock's liquidity remains adequate for trades up to Rs 1.26 crore, based on 2% of the 5-day average traded value. Overall, the increase in open interest and the stock's recent performance highlight a significant moment for Piramal Pharma in the current market landscape.